ReviewTherapeutic advances in gastroenterology2022

Pemigatinib for adults with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions/rearrangements.

Daniel Walden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.